Tony Coles is the founder of Cerevel Therapeutics. Cerevel Therapeutics has raised $445M in total funding. Latest round: IPO. Backed by Perceptive Advisors.
Tony Coles is an experienced biotech executive who has led Cerevel Therapeutics, a neuroscience company, since 2019. He was instrumental in establishing and advancing a drug discovery platform for a number of diseases, including Parkinson's disease, related synuclein disorders, and Amyotrophic Lateral Sclerosis. He previously served as President, CEO, and Chairman of Onyx Pharmaceuticals.
Full founder directory · Investor directory · Company funding database · Fundraising library